CSPC Pharmaceutical Group (01093) said its profit attributable to shareholders for the three months ended 31 March 2015 rose 53.3% year-on-year to HK$400 million.
The basic and diluted earnings per share were HK6.78 cents and HK6.71 cents.
The revenue was HK$2,782 million, an increase of 7.7% from a year earlier.
WoW WoW星期三：健康網購產品低至$99 (只限今天)► 立即行動
